Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer. Chen K, McVey A, Kasivisvanathan V, Jenjitranant P, et al. Eur Urol 2022 Mar 25. pii: S0302-2838(22)01789.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen K, McVey A, Kasivisvanathan V, Jenjitranant P, et al. Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer. Eur Urol 2022 Mar 25. pii: S0302-2838(22)01789.
PMID: 35346516